[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @FiercePharma FiercePharma FiercePharma posts on X about breast cancer, $8750t, breakthrough, $4503t the most. They currently have XXXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::18294275/interactions)  - X Week XXXXXX +351% - X Month XXXXXX +51% - X Months XXXXXXX -XX% - X Year XXXXXXX -XXXX% ### Mentions: XX [#](/creator/twitter::18294275/posts_active)  - X Week XX +40% - X Month XX +2.90% - X Months XXX -XX% - X Year XXX +30% ### Followers: XXXXXX [#](/creator/twitter::18294275/followers)  - X Week XXXXXX +0.05% - X Month XXXXXX +0.21% - X Months XXXXXX +0.92% - X Year XXXXXX +0.53% ### CreatorRank: XXXXXXX [#](/creator/twitter::18294275/influencer_rank)  ### Social Influence [#](/creator/twitter::18294275/influence) --- **Social category influence** [stocks](/list/stocks) XXXX% **Social topic influence** [breast cancer](/topic/breast-cancer) #249, [$8750t](/topic/$8750t) #4, [breakthrough](/topic/breakthrough) 1.03%, [$4503t](/topic/$4503t) 1.03%, [$445m](/topic/$445m) 1.03%, [white house](/topic/white-house) 1.03%, [os](/topic/os) 1.03%, [novartis](/topic/novartis) 1.03%, [trumps](/topic/trumps) 1.03%, [sanofi](/topic/sanofi) XXXX% **Top accounts mentioned or mentioned by** [@persimmonti](/creator/undefined) [@astellasus](/creator/undefined) [@daviddin](/creator/undefined) [@conkers3](/creator/undefined) [@mateosagan](/creator/undefined) [@doccjc62](/creator/undefined) [@braincures](/creator/undefined) [@lux_capital](/creator/undefined) [@polaronfinance](/creator/undefined) [@biogerontology](/creator/undefined) [@smallcapbob2](/creator/undefined) [@alnylam](/creator/undefined) [@healthcarewen](/creator/undefined) [@jacks24450](/creator/undefined) [@boback](/creator/undefined) [@disgustedbuthpl](/creator/undefined) [@snackbiotech](/creator/undefined) [@independentsol4](/creator/undefined) [@mendaerainc](/creator/undefined) [@curtistradesca](/creator/undefined) **Top assets mentioned** [Novartis AG (NVS)](/topic/novartis) [Sanofi (SNY)](/topic/sanofi) ### Top Social Posts [#](/creator/twitter::18294275/posts) --- Top posts by engagements in the last XX hours "Pfizer and Astellas' Padcev plus Keytruda delivers 'breakthrough' win in new bladder cancer use" [X Link](https://x.com/FiercePharma/status/1955337237056336244) [@FiercePharma](/creator/x/FiercePharma) 2025-08-12T18:35Z 99.9K followers, 2112 engagements "Pfizer's Lorviqua nabs NICE thumbs up after initial rejection" [X Link](https://x.com/FiercePharma/status/1976303590789743006) [@FiercePharma](/creator/x/FiercePharma) 2025-10-09T15:07Z 99.9K followers, 1830 engagements "AstraZeneca to spend $445M to boost production of Lokelma at Texas plant" [X Link](https://x.com/FiercePharma/status/1978537724534571136) [@FiercePharma](/creator/x/FiercePharma) 2025-10-15T19:05Z 99.9K followers, 1686 engagements "Regeneron's Libtayo gains 'practice-changing' skin cancer label expansion" [X Link](https://x.com/FiercePharma/status/1976334887058624847) [@FiercePharma](/creator/x/FiercePharma) 2025-10-09T17:12Z 99.9K followers, 2654 engagements "Novo Nordisk is ending all work in cell therapy including a Type X diabetes program amid CEO Maziar Mike Doustdar's reorganization" [X Link](https://x.com/FiercePharma/status/1977732375845990758) [@FiercePharma](/creator/x/FiercePharma) 2025-10-13T13:45Z 99.9K followers, 3974 engagements "AstraZeneca CEO visits White House to formalize MFN agreement with Trump" [X Link](https://x.com/FiercePharma/status/1977790274517586167) [@FiercePharma](/creator/x/FiercePharma) 2025-10-13T17:35Z 99.9K followers, 2967 engagements "Merck's Keytruda follows primary endpoint win in ovarian cancer study with OS triumph" [X Link](https://x.com/FiercePharma/status/1978915348536869266) [@FiercePharma](/creator/x/FiercePharma) 2025-10-16T20:06Z 99.9K followers, 2447 engagements "AstraZeneca Daiichi unleash Enhertu's 2-fisted power aiming to reshape early breast cancer landscape. #ESMO25" [X Link](https://x.com/FiercePharma/status/1979557754680529175) [@FiercePharma](/creator/x/FiercePharma) 2025-10-18T14:38Z 99.9K followers, XXX engagements "Novartis advances IgAN efforts with phase X win for Fabhalta plots FDA filing for full approval" [X Link](https://x.com/FiercePharma/status/1978917361747931642) [@FiercePharma](/creator/x/FiercePharma) 2025-10-16T20:14Z 99.9K followers, 2499 engagements "Merck KGaAs EMD Serono strikes MFN deal in Trump's fertility treatment pricing push" [X Link](https://x.com/FiercePharma/status/1979272497951576295) [@FiercePharma](/creator/x/FiercePharma) 2025-10-17T19:45Z 99.9K followers, 1702 engagements "Sanofi gets one thumbs up one thumbs down from Europe's CHMP" [X Link](https://x.com/FiercePharma/status/1979275472891732235) [@FiercePharma](/creator/x/FiercePharma) 2025-10-17T19:57Z 99.9K followers, 2211 engagements "AstraZeneca Daiichi unleash Enhertu's 2-fisted power aiming to reshape early breast cancer landscape. #ESMO25" [X Link](https://x.com/FiercePharma/status/1979559794106331391) [@FiercePharma](/creator/x/FiercePharma) 2025-10-18T14:46Z 99.9K followers, 1702 engagements "Merck's Keytruda becomes part of the first immune checkpoint inhibitor-based regimen to prove a survival benefit in ovarian cancer #ESMO25" [X Link](https://x.com/FiercePharma/status/1979578145545097318) [@FiercePharma](/creator/x/FiercePharma) 2025-10-18T15:59Z 99.9K followers, 1575 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
FiercePharma posts on X about breast cancer, $8750t, breakthrough, $4503t the most. They currently have XXXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.
Social category influence stocks XXXX%
Social topic influence breast cancer #249, $8750t #4, breakthrough 1.03%, $4503t 1.03%, $445m 1.03%, white house 1.03%, os 1.03%, novartis 1.03%, trumps 1.03%, sanofi XXXX%
Top accounts mentioned or mentioned by @persimmonti @astellasus @daviddin @conkers3 @mateosagan @doccjc62 @braincures @lux_capital @polaronfinance @biogerontology @smallcapbob2 @alnylam @healthcarewen @jacks24450 @boback @disgustedbuthpl @snackbiotech @independentsol4 @mendaerainc @curtistradesca
Top assets mentioned Novartis AG (NVS) Sanofi (SNY)
Top posts by engagements in the last XX hours
"Pfizer and Astellas' Padcev plus Keytruda delivers 'breakthrough' win in new bladder cancer use"
X Link @FiercePharma 2025-08-12T18:35Z 99.9K followers, 2112 engagements
"Pfizer's Lorviqua nabs NICE thumbs up after initial rejection"
X Link @FiercePharma 2025-10-09T15:07Z 99.9K followers, 1830 engagements
"AstraZeneca to spend $445M to boost production of Lokelma at Texas plant"
X Link @FiercePharma 2025-10-15T19:05Z 99.9K followers, 1686 engagements
"Regeneron's Libtayo gains 'practice-changing' skin cancer label expansion"
X Link @FiercePharma 2025-10-09T17:12Z 99.9K followers, 2654 engagements
"Novo Nordisk is ending all work in cell therapy including a Type X diabetes program amid CEO Maziar Mike Doustdar's reorganization"
X Link @FiercePharma 2025-10-13T13:45Z 99.9K followers, 3974 engagements
"AstraZeneca CEO visits White House to formalize MFN agreement with Trump"
X Link @FiercePharma 2025-10-13T17:35Z 99.9K followers, 2967 engagements
"Merck's Keytruda follows primary endpoint win in ovarian cancer study with OS triumph"
X Link @FiercePharma 2025-10-16T20:06Z 99.9K followers, 2447 engagements
"AstraZeneca Daiichi unleash Enhertu's 2-fisted power aiming to reshape early breast cancer landscape. #ESMO25"
X Link @FiercePharma 2025-10-18T14:38Z 99.9K followers, XXX engagements
"Novartis advances IgAN efforts with phase X win for Fabhalta plots FDA filing for full approval"
X Link @FiercePharma 2025-10-16T20:14Z 99.9K followers, 2499 engagements
"Merck KGaAs EMD Serono strikes MFN deal in Trump's fertility treatment pricing push"
X Link @FiercePharma 2025-10-17T19:45Z 99.9K followers, 1702 engagements
"Sanofi gets one thumbs up one thumbs down from Europe's CHMP"
X Link @FiercePharma 2025-10-17T19:57Z 99.9K followers, 2211 engagements
"AstraZeneca Daiichi unleash Enhertu's 2-fisted power aiming to reshape early breast cancer landscape. #ESMO25"
X Link @FiercePharma 2025-10-18T14:46Z 99.9K followers, 1702 engagements
"Merck's Keytruda becomes part of the first immune checkpoint inhibitor-based regimen to prove a survival benefit in ovarian cancer #ESMO25"
X Link @FiercePharma 2025-10-18T15:59Z 99.9K followers, 1575 engagements
/creator/twitter::FiercePharma